161 related articles for article (PubMed ID: 37893077)
1. Loss of Anti-Tumor Efficacy by Polyamine Blocking Therapy in GCN2 Null Mice.
Alexander ET; Fahey E; Phanstiel O; Gilmour SK
Biomedicines; 2023 Oct; 11(10):. PubMed ID: 37893077
[TBL] [Abstract][Full Text] [Related]
2. Polyamine Blocking Therapy Decreases Survival of Tumor-Infiltrating Immunosuppressive Myeloid Cells and Enhances the Antitumor Efficacy of PD-1 Blockade.
Alexander ET; Mariner K; Donnelly J; Phanstiel O; Gilmour SK
Mol Cancer Ther; 2020 Oct; 19(10):2012-2022. PubMed ID: 32747421
[TBL] [Abstract][Full Text] [Related]
3. A novel polyamine blockade therapy activates an anti-tumor immune response.
Alexander ET; Minton A; Peters MC; Phanstiel O; Gilmour SK
Oncotarget; 2017 Oct; 8(48):84140-84152. PubMed ID: 29137411
[TBL] [Abstract][Full Text] [Related]
4. GCN2 drives macrophage and MDSC function and immunosuppression in the tumor microenvironment.
Halaby MJ; Hezaveh K; Lamorte S; Ciudad MT; Kloetgen A; MacLeod BL; Guo M; Chakravarthy A; Medina TDS; Ugel S; Tsirigos A; Bronte V; Munn DH; Pugh TJ; De Carvalho DD; Butler MO; Ohashi PS; Brooks DG; McGaha TL
Sci Immunol; 2019 Dec; 4(42):. PubMed ID: 31836669
[TBL] [Abstract][Full Text] [Related]
5. Polyamine-blocking therapy reverses immunosuppression in the tumor microenvironment.
Hayes CS; Shicora AC; Keough MP; Snook AE; Burns MR; Gilmour SK
Cancer Immunol Res; 2014 Mar; 2(3):274-85. PubMed ID: 24778323
[TBL] [Abstract][Full Text] [Related]
6. The stress kinase GCN2 does not mediate suppression of antitumor T cell responses by tryptophan catabolism in experimental melanomas.
Sonner JK; Deumelandt K; Ott M; Thomé CM; Rauschenbach KJ; Schulz S; Munteanu B; Mohapatra S; Adam I; Hofer AC; Feuerer M; Opitz CA; Hopf C; Wick W; Platten M
Oncoimmunology; 2016; 5(12):e1240858. PubMed ID: 28123877
[TBL] [Abstract][Full Text] [Related]
7. Polyamine Depletion Strategies in Cancer: Remodeling the Tumor Immune Microenvironment to Enhance Anti-Tumor Responses.
Chin A; Bieberich CJ; Stewart TM; Casero RA
Med Sci (Basel); 2022 Jun; 10(2):. PubMed ID: 35736351
[TBL] [Abstract][Full Text] [Related]
8. Differential Expression of Polyamine Pathways in Human Pancreatic Tumor Progression and Effects of Polyamine Blockade on Tumor Microenvironment.
Nakkina SP; Gitto SB; Pandey V; Parikh JG; Geerts D; Maurer HC; Olive KP; Phanstiel O; Altomare DA
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34945011
[TBL] [Abstract][Full Text] [Related]
9. Myeloid-derived suppressor cells accumulate among myeloid cells contributing to tumor growth in matrix metalloproteinase 12 knockout mice.
Li J; Zhang X; Liu Q; Yang M; Zhou Z; Ye Y; Zhou Z; He X; Wang L
Cell Immunol; 2018 May; 327():1-12. PubMed ID: 29555056
[TBL] [Abstract][Full Text] [Related]
10. Potent GCN2 Inhibitor Capable of Reversing MDSC-Driven T Cell Suppression Demonstrates In Vivo Efficacy as a Single Agent and in Combination with Anti-Angiogenesis Therapy.
Jackson JJ; Shibuya GM; Ravishankar B; Adusumilli L; Bradford D; Brockstedt DG; Bucher C; Bui M; Cho C; Colas C; Cutler G; Dukes A; Han X; Hu DX; Jacobson S; Kassner PD; Katibah GE; Ko MYM; Kolhatkar U; Leger PR; Ma A; Marshall L; Maung J; Ng AA; Okano A; Pookot D; Poon D; Ramana C; Reilly MK; Robles O; Schwarz JB; Shakhmin AA; Shunatona HP; Sreenivasan R; Tivitmahaisoon P; Xu M; Zaw T; Wustrow DJ; Zibinsky M
J Med Chem; 2022 Oct; 65(19):12895-12924. PubMed ID: 36127295
[TBL] [Abstract][Full Text] [Related]
11. T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma.
Wang X; Zhang Q; Zhou J; Xiao Z; Liu J; Deng S; Hong X; Huang W; Cai M; Guo Y; Huang J; Wang Y; Lin L; Zhu K
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36813307
[TBL] [Abstract][Full Text] [Related]
12. Selective control of amino acid metabolism by the GCN2 eIF2 kinase pathway in Saccharomyces cerevisiae.
Zaborske JM; Wu X; Wek RC; Pan T
BMC Biochem; 2010 Aug; 11():29. PubMed ID: 20684782
[TBL] [Abstract][Full Text] [Related]
13. Valproic acid attenuates CCR2-dependent tumor infiltration of monocytic myeloid-derived suppressor cells, limiting tumor progression.
Xie Z; Ikegami T; Ago Y; Okada N; Tachibana M
Oncoimmunology; 2020; 9(1):1734268. PubMed ID: 32158627
[TBL] [Abstract][Full Text] [Related]
14. Myeloid-Derived Suppressor Cells Impair B Cell Responses in Lung Cancer through IL-7 and STAT5.
Wang Y; Schafer CC; Hough KP; Tousif S; Duncan SR; Kearney JF; Ponnazhagan S; Hsu HC; Deshane JS
J Immunol; 2018 Jul; 201(1):278-295. PubMed ID: 29752311
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-155 deficiency enhances the recruitment and functions of myeloid-derived suppressor cells in tumor microenvironment and promotes solid tumor growth.
Wang J; Yu F; Jia X; Iwanowycz S; Wang Y; Huang S; Ai W; Fan D
Int J Cancer; 2015 Mar; 136(6):E602-13. PubMed ID: 25143000
[TBL] [Abstract][Full Text] [Related]
16. The role of polyamine metabolism in remodeling immune responses and blocking therapy within the tumor immune microenvironment.
Lian J; Liang Y; Zhang H; Lan M; Ye Z; Lin B; Qiu X; Zeng J
Front Immunol; 2022; 13():912279. PubMed ID: 36119047
[TBL] [Abstract][Full Text] [Related]
17. Activation of GCN2 in macrophages promotes white adipose tissue browning and lipolysis under leucine deprivation.
Wang F; Xiao F; Du L; Niu Y; Yin H; Zhou Z; Jiang X; Jiang H; Yuan F; Liu K; Chen S; Duan S; Guo F
FASEB J; 2021 Jun; 35(6):e21652. PubMed ID: 34004054
[TBL] [Abstract][Full Text] [Related]
18. Prim-O-glucosylcimifugin enhances the antitumour effect of PD-1 inhibition by targeting myeloid-derived suppressor cells.
Gao W; Zhang X; Yang W; Dou D; Zhang H; Tang Y; Zhong W; Meng J; Bai Y; Liu Y; Yang L; Chen S; Liu H; Yang C; Sun T
J Immunother Cancer; 2019 Aug; 7(1):231. PubMed ID: 31462297
[TBL] [Abstract][Full Text] [Related]
19. Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy.
Adeshakin AO; Liu W; Adeshakin FO; Afolabi LO; Zhang M; Zhang G; Wang L; Li Z; Lin L; Cao Q; Yan D; Wan X
Cell Immunol; 2021 Apr; 362():104286. PubMed ID: 33524739
[TBL] [Abstract][Full Text] [Related]
20. The eIF2 kinase GCN2 is essential for the murine immune system to adapt to amino acid deprivation by asparaginase.
Bunpo P; Cundiff JK; Reinert RB; Wek RC; Aldrich CJ; Anthony TG
J Nutr; 2010 Nov; 140(11):2020-7. PubMed ID: 20861212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
